Healthcare -
Biotechnology - NASDAQ - US
$ 54.28
1.79 %
$ 4.33 B
Market Cap
-14.12
P/E
AKRO - NET INCOME
Net Income AKRO - Akero Therapeutics, Inc.
-252 M
LAST VALUE
-50.00%
2 YEAR CAGR
-41.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR